Αποτελέσματα Αναζήτησης
The Citicoline Brain Injury Treatment Trial (COBRIT) was a Phase III, double-blind, randomized, clinical trial conducted between 2007 and 2011 among 1,213 patients at eight US level 1 trauma centers, in order to investigate the effects of citicoline vs placebo in patients with traumatic brain injury (TBI), classified as complicated mild ...
- Role of Citicoline in Patients With Mild Cognitive Impairment
Diverse studies have revealed the efficacy of citicoline for...
- Neuroprotective Properties of Citicoline: Facts, Doubts and Unresolved ...
Key Points for Decision Makers. Citicoline is chemically...
- Citicoline: pharmacological and clinical review, 2006 update
Citicoline activates biosynthesis of structural...
- Role of Citicoline in Patients With Mild Cognitive Impairment
16 Φεβ 2023 · Diverse studies have revealed the efficacy of citicoline for the treatment of mild cognitive impairment, which is usually administered orally as monotherapy (Table 1). 7,17,18 The open-label, multicenter, Italian IDEALE study compared the effectiveness and safety of the administration of oral citicoline (1 g/day) in 265 patients with vascular ...
Used in medicine as a drug since the 1980-s, citicoline was recently pronounced a food ingredient. ... brain levels of choline measured by 1 H-MRS were lower in the aged group, suggestive of a decrease in choline uptake into the brain with age. ... 1 study lasted 6 weeks, 4 studies lasted 2 and 3 months, and 1 study lasted 12 months. Multiple ...
Key Points for Decision Makers. Citicoline is chemically identical to CDP-choline, the natural precursor of the major cell membrane phospholipid phosphatidylcholine. Given orally or by injection, citicoline is non-toxic and very well tolerated.
30 Νοε 2022 · Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol 2016; 63 (Supl 3): S1-S73), incorporating 176 new references, having all the information available in the same document to facilitate the access to the inf …
27 Δεκ 2022 · This review is focused on the main indications of the drug, as acute stroke and its sequelae, including the cognitive impairment, and traumatic brain injury and its sequelae. There are retrieved...
Citicoline activates biosynthesis of structural phospholipids of neuronal membranes, increases brain metabolism, and acts upon the levels of different neurotransmitters. Thus, citicoline has been experimentally shown to increase norepinephrine and dopamine levels in the CNS.
